Aviva Systems Biology Recognized as the 2024 Bioz Rapid Star for Antibody Excellence
We are thrilled to share that Aviva Systems Biology has received the Bioz Rapid Star Award in the Antibodies category! This recognition reflects both the quality of our antibody portfolio and the groundbreaking work of the researchers who use our products to advance life sciences.
.png?width=581&height=145&name=Bioz%20email%20Hero%20(1200%20x%20300%20px).png)
The Bioz Rapid Star Award is based on citations from peer-reviewed publications, making it a meaningful acknowledgment of real-world performance. With over 80,000 antibodies available, Aviva has become a trusted partner for scientists who need reliable, validated tools to fuel their discoveries.
A Testament to Our Customers' Hard Work
This award is as much about our customers as it is about us. We know how much time and care goes into each experiment, and we're proud to support that effort with antibodies that perform consistently and reproducibly. Seeing our antibodies cited in publications across various fields is incredibly rewarding, and it motivates us to keep raising the bar.
Innovation on the Horizon: Next-Gen Recombinant Antibodies
While we celebrate this milestone, we’re also looking ahead. Aviva is investing heavily in the development of next-generation recombinant monoclonal antibodies. These antibodies offer superior specificity, reproducibility, and consistency, making them ideal for even the most demanding applications. Stay tuned for exciting updates as we expand our recombinant antibody offerings.
Explore Our Cited Products
Don’t just take our word for it - see the data for yourself. Our antibodies have been cited in numerous peer-reviewed publications, supporting research across neuroscience, oncology, immunology, and more.
We want to thank our customers for choosing Aviva antibodies as part of their research journey. This award validates your trust in our products and reaffirms our commitment to supporting your success with best-in-class antibody solutions.
Here’s to more discoveries ahead 🎉
